SLC9B1P2: A Potential Drug Target and Biomarker for Ion and Water Balance Disorders

Target Name: SLC9B1P2

NCBI ID: G389000

SLC9B1P2

Other Name(s): NHEDC1P2 | Solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1 pseudogene 2 | solute carrier family 9 member B1 pseudogene 2

SLC9B1P2: A Potential Drug Target and Biomarker for Ion and Water Balance Disorders

SLC9B1P2 (NHEDC1P2) is a protein that is expressed in various tissues throughout the body. It is a member of the NHEJ family, which is a type of transmembrane protein that plays an important role in the regulation of ion and water transport in various organisms. SLC9B1P2 is also known as GLUT2, which stands for GLUT2-associated protein.

SLC9B1P2 is a 21-kDa protein that is expressed in the brain, heart, liver, and kidneys. It is primarily localized to the endoplasmic reticulum (ER), which is the protein synthesis and modification organ of the cell. SLC9B1P2 is also found in the cytoplasm and is considered to be a cytoplasmic protein.

SLC9B1P2 is involved in a number of cellular processes that are important for maintaining cellular homeostasis. One of its key functions is in the regulation of ion and water transport. SLC9B1P2 is a critical regulator of the diffusion of Na+ and K+ ions across the endothelial cell membrane . It is also involved in the regulation of water transport, as it is a transmembrane protein that is involved in the regulation of the water uptake and release of various cells.

SLC9B1P2 is also involved in the regulation of cellular signaling pathways. It is a negative regulator of the TGF-β pathway, which is a well-known signaling pathway that is involved in the regulation of cellular growth, differentiation, and inflammation. a negative regulator of the NF-kappa-B pathway, which is involved in the regulation of inflammation and inflammation-related processes.

SLC9B1P2 is a potential drug target for a number of diseases. One of its key functions as a regulator of ion and water transport makes it a potential target for diseases that are characterized by disorders related to ion and water balance. For example, SLC9B1P2-related Mutations have been identified in a number of diseases, including hypertension, heart failure, and neurodegenerative diseases.

SLC9B1P2 is also a potential biomarker for a number of diseases. Its involvement in the regulation of ion and water transport makes it a potential target for diseases that are characterized by disorders related to these processes. For example, SLC9B1P2 has been identified as a potential biomarker for heart failure, as its expression is often altered in patients with heart failure. It is also a potential biomarker for neurodegenerative diseases, as its expression is often altered in these diseases.

In conclusion, SLC9B1P2 is a protein that is involved in a number of cellular processes that are important for maintaining cellular homeostasis. Its regulation of ion and water transport, as well as its involvement in cellular signaling pathways, makes it a potential drug target and biomarker for a number of diseases. Further research is needed to fully understand the role of SLC9B1P2 in these processes and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: Solute Carrier Family 9 Member B1 Pseudogene 2

The "SLC9B1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC9B1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets